Engineered Regeneration (ER) is a scholarly journal dedicated to publishing research in the field of Medicine, and Published by KeAi Communications Co. and its abbreviation is Eng Regen.
The latest Impact Factor of the Engineered Regeneration for 2026-2027 is 5.2.
The Publication fees (APC) is 840 USD.
Engineered Regeneration (ER) is a peer reviewed, fully Open Access journal that advances the biomedical field with cutting-edge research and applications on all aspects of tissue growth, regeneration, and repair. This multidisciplinary preeminent journal brings together the principles of engineering and life sciences in engineering-driven medicine. The journal provides a central forum for groundbreaking scientific research and developments of clinical applications that will contribute to the ultimate care of patients.
| Journal title | Engineered Regeneration (ER) |
| Abbreviation | Eng Regen |
| Online ISSN | 2666-1381 |
| Publisher Name | KeAi Communications Co |
| Editor-in-chief | Yuanjin Zhao |
| Subject Category | Medicine |
| Access type | 🔒 Subscription |
| Status | 🟢 Active |
In the context of academic journals, "Metrics and Rankings" refer to various measures and evaluations used to assess the quality, influence, and impact of a journal.
Below are the metrics and rankings for the journal Engineered Regeneration
| Impact Factor | 5.2 |
| SJR | 3.250 |
| SNIP | 3.955 |
| Ranking | 535 |
| CiteScore | 15.2 |
| H-Index | 19 |
| Quartile | Q1 |
Abstracting and Indexing (A&I) refers to the processes that help organize and categorize academic journals, making them easier to find and access for researchers and scholars
| Abstracting and Indexing |
If you would like to submit a manuscript or visit the journal's website, please click on the link below.
| Journal Submission | 🔗 Journal Website |
Add the app to your device for one-tap access.